Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients
Clinical trial NCT07620561 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07620561
- Sponsor
- University of Maryland, Baltimore
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.